UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037075
Receipt number R000042246
Scientific Title Dose the use of low osmolality contrast media reduce the frequency of post-ERCP pancreatitis? : a comparative study between use of low and high osmolality contrast media.
Date of disclosure of the study information 2019/06/15
Last modified on 2019/06/15 00:10:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Dose the use of low osmolality contrast media reduce the frequency of post-ERCP pancreatitis? : a comparative study between use of low and high osmolality contrast media.

Acronym

Effect of low osmolality contrast media in post-ERCP pancreatitis

Scientific Title

Dose the use of low osmolality contrast media reduce the frequency of post-ERCP pancreatitis? : a comparative study between use of low and high osmolality contrast media.

Scientific Title:Acronym

Effect of low osmolality contrast media in post-ERCP pancreatitis

Region

Japan


Condition

Condition

Gastroenterology

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether low-osmotic contrast agent iodixanol suppresses post-ERCP pancreatitis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

PEP incidence rate by contrast agent

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

28 years-old <=

Age-upper limit

95 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who underwent ERCP from October 2015 to December 2016.

Key exclusion criteria

Cases treated with nipple treatments such as endoscopic sphincterotomy (EST) and endoscopic papillary balloon dilation (EPBD), cases with underlying malignancy, and cases with acute pancreatitis at the time of ERCP (cholecystolitic inflammation cases) , A case of reconstructed intestinal tract case, a self-expandable metal stent (SEMS) indwelling case, a case in which a pancreatic duct stent was indwelled after ERCP as PEP prevention

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Kazunori
Middle name
Last name Nagashima

Organization

Dokkyo Medical University

Division name

Department of Gastroenterology

Zip code

321-0293

Address

tochigi,shimotugagunn,mibumachi,kitakobayashi-880

TEL

0282-86-1111

Email

n-kazu@dokkyomed.ac.jp


Public contact

Name of contact person

1st name Kazunori
Middle name
Last name Nagashima

Organization

Dokkyo Medical University

Division name

Department of Gastroenterology

Zip code

321-0293

Address

tochigi,shimotugagunn,mibumachi,kitakobayashi-880

TEL

0282-86-1111

Homepage URL


Email

n-kazu@dokkyomed.ac.jp


Sponsor or person

Institute

oota,memorial,hospital

Institute

Department

Personal name



Funding Source

Organization

no

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

dokkyo-Medical-University

Address

tochigi,shimotugagunn,mibumachi,kitakobayashi-880

Tel

0282-86-1111

Email

n-kazu@dokkyomed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

250

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 10 Month 01 Day

Date of IRB

2018 Year 02 Month 21 Day

Anticipated trial start date

2015 Year 10 Month 02 Day

Last follow-up date

2019 Year 06 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

no


Management information

Registered date

2019 Year 06 Month 15 Day

Last modified on

2019 Year 06 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042246


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name